The Holiday Season Could Be Make-or-Break for Cannabis Stocks

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) is looking like a leading stock for brand-conscious cannabis investors.

| More on:
edit Jars of marijuana

Image source: Getty Images

Cannabis stocks were rallying before the weekend, with a number of key stocks carrying the positive momentum over into the start of the week. For observers used to an event-driven industry, the largely value-induced rally may have come as something of a surprise.

Other pundits were quick to point out the influence of entertainer Drake, whose partnership with Canopy Growth saw the stock jump 9%.

Pot stocks have seen some intense price volatility in the past two weeks, as traders make the most of oscillating prices in the ramp up for the holiday period. In fact, winter sales could be a significant watershed moment for cannabis stocks now that the full gamut of marijuana asset types is finally available legally.

Cannabis investors need 2020 vision

HEXO (TSX:HEXO)(NYSE:HEXO) is moving into a price-competitive position to target the black market ahead of the holidays. Next year will be make-or-break for legal pot, with four main factors determining how successful Canadian cannabis companies are this holiday season, namely: Health Canada constraints, the number of retail outlets selling cannabis products, supplies, and the market itself.

All four factors could put a crimp in cannabis companies’ projected sales. With packaging likely to be plain and not enough actual stores to buy from, the retail scene could be decidedly frosty over the next couple months.

Over-supply and a crowded playing field also mean that companies could find it hard to command high prices and a big enough market share, while demand on the customer side could also flag.

A breakthrough in time for the festive season?

Another key development that could shake out in favour of cannabis producers leaning into the vaping industry is the news that vitamin E acetate seems to be a common molecule present in all cases of vape-related lung injuries investigated by the Centers for Disease Control and Prevention (CDC).

Why is this good news? Well, if a harmful element can be removed from vape products, then the industry may not be dead in the water after all.

However, the CDC has cautioned that the finding is tentative and that other substances have not yet been ruled out as causative factors in the rash of vaping-induced illnesses.

While it’s too early to take this as a buy signal for companies invested in the vaping craze, investors should take a wait-and-see stance. For now, the CDC’s warning to avoid THC vapes remains in place.

In the meantime, other cannabis 2.0 asset types recently released into the wild, notably cannabis-laced drinks, could make a big splash over the holiday period.

HEXO and Molson Coors partnered up to form Truss, a marijuana beverage brand that is slated to begin pumping its cannabis-laden liquids into the market at some point in December. The Canadian market is valued at more than $500 million a year.

The bottom line

The holiday period is looking like a strategic watershed for sales, with all of the ducks finally lined up for Canadian companies. Investors will be taking note in the new year, with holiday sales likely to determine which pot producers gain dominance over the market.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »